Skip to content
MS
PW-028 Nucleotide Metabolism Catabolic unreviewed

Pyrimidine Degradation

CMP / UMP / dTMP Beta-alanine or beta-aminoisobutyrate + NH3 + CO2
Compartment
Cytosol
Main tissue
Liver
Rate-limiting
Dihydropyrimidine dehydrogenase (DPD)
Steps
14

Reaction steps

In source order, 14 total

showing 1–14
  1. 1

    UMP → uridine

    5'-Nucleotidase (NT5C/NT5E) 3.1.3.5 ST-0238 Irreversible/directional H2O Pi
    In UMP
    Out Uridine
    Notes

    5′-Nucleotidase catalyzes UMP + H2O → uridine + Pi. CMP, TMP, and their deoxy counterparts are likewise dephosphorylated by nucleotide phosphatases/nucleotidases before nucleoside or base breakdown.

  2. 2

    CMP (or cytidine) → uridine

    Cytidine deaminase 3.5.4.5 ST-0239 Irreversible/directional H2O
    In CMP
    Out Uridine
    Notes

    Cytidine deaminase catalyzes cytidine + H2O → uridine + NH3; after CMP is dephosphorylated, this reaction funnels cytosine nucleosides into uracil catabolism. Cytidine deaminase also acts on deoxycytidine to form deoxyuridine and is clinically important in nucleoside drug metabolism.

  3. 3

    Uridine → uracil

    Uridine phosphorylase 2.4.2.3 ST-0240 Irreversible/directional Pi
    In Uridine
    Out Uracil
    Notes

    Uridine phosphorylase catalyzes uridine + Pi ⇌ uracil + ribose 1-phosphate. Deoxyuridine can similarly be phosphorolyzed to uracil plus deoxyribose 1-phosphate.

  4. 4

    TMP → thymidine

    5'-Nucleotidase (NT5C/NT5E) 3.1.3.5 ST-0241 Irreversible/directional H2O Pi
    In dTMP
    Out Thymidine
    Notes

    5′-Nucleotidase catalyzes TMP + H2O → thymidine + Pi.

  5. 5

    Thymidine → thymine

    Thymidine phosphorylase 2.4.2.4 ST-0242 Irreversible/directional Pi
    Notes

    Thymidine phosphorylase catalyzes thymidine + Pi ⇌ thymine + 2-deoxyribose 1-phosphate. The reaction also participates in thymidine salvage, depending on metabolite concentrations.

  6. 6

    Uracil → 5,6-dihydrouracil

    Dihydropyrimidine dehydrogenase (DPD) 1.3.1.2 ST-0243 Irreversible/directional rate-limiting NADP+ NADPH
    Notes

    DPD catalyzes uracil + NADPH + H+ → 5,6-dihydrouracil + NADP+. DPD is a large flavoprotein/iron-sulfur enzyme requiring FAD, FMN, and NADPH; this NADPH-dependent reduction is the rate-limiting step of pyrimidine degradation.

  7. 7

    Thymine → 5,6-dihydrothymine

    Dihydropyrimidine dehydrogenase (DPD) 1.3.1.2 ST-0244 Irreversible/directional rate-limiting NADP+ NADPH
    Notes

    DPD catalyzes thymine + NADPH + H+ → 5,6-dihydrothymine + NADP+. The same rate-limiting enzyme handles both major pyrimidine bases.

  8. 8

    5,6-Dihydrouracil → N-carbamyl-beta-alanine

    Dihydropyrimidinase 3.5.2.2 ST-0245 Irreversible/directional H2O
    Notes

    Dihydropyrimidinase hydrolyzes the reduced ring: 5,6-dihydrouracil + H2O → N-carbamyl-beta-alanine. This metalloenzyme opens the pyrimidine ring.

  9. 9

    5,6-Dihydrothymine → N-carbamyl-beta-aminoisobutyrate

    Dihydropyrimidinase 3.5.2.2 ST-0246 Irreversible/directional H2O
    Notes

    Dihydropyrimidinase catalyzes 5,6-dihydrothymine + H2O → N-carbamyl-beta-aminoisobutyrate.

  10. 10

    N-Carbamyl-beta-alanine → beta-alanine

    Beta-ureidopropionase 3.5.1.6 ST-0247 Irreversible/directional H2O
    Notes

    Beta-ureidopropionase catalyzes N-carbamyl-beta-alanine + H2O → beta-alanine + NH3 + CO2. This completes the uracil-derived ring-carbon/nitrogen disposal sequence.

  11. 11

    N-Carbamyl-beta-aminoisobutyrate → beta-aminoisobutyrate

    Beta-ureidopropionase 3.5.1.6 ST-0248 Irreversible/directional H2O
    Notes

    Beta-ureidopropionase catalyzes N-carbamyl-beta-aminoisobutyrate + H2O → beta-aminoisobutyrate + NH3 + CO2.

  12. 12

    Beta-alanine → malonate semialdehyde → acetyl-CoA

    ↪ malonate semialdehyde → acetyl-CoA

    Beta-alanine transaminase (AGXT2) 2.6.1.19 ST-0249 Irreversible/directional
    Notes

    Beta-alanine transaminase (largely AGXT2-associated activity) transfers the amino group of beta-alanine to an alpha-ketoacid acceptor, producing malonate semialdehyde. Malonate-semialdehyde dehydrogenase (ALDH6A1) then catalyzes oxidative decarboxylation of malonate semialdehyde with CoA and NAD+ to form acetyl-CoA, CO2, and NADH; exact transaminase partners vary by tissue.

  13. 13

    Beta-aminoisobutyrate → methylmalonate semialdehyde → propionyl-CoA

    ↪ methylmalonate semialdehyde → propionyl-CoA

    Notes

    Beta-aminoisobutyrate transaminase generates methylmalonate semialdehyde, which methylmalonate-semialdehyde dehydrogenase (ALDH6A1) converts using CoA and NAD+ to propionyl-CoA + CO2 + NADH.

  14. 14

    Propionyl-CoA → succinyl-CoA

    Notes

    Propionyl-CoA carboxylase uses ATP, bicarbonate, and biotin to convert propionyl-CoA to D-methylmalonyl-CoA; methylmalonyl-CoA epimerase produces L-methylmalonyl-CoA; and adenosylcobalamin-dependent methylmalonyl-CoA mutase rearranges it to succinyl-CoA. These downstream steps permit thymine carbon to enter the tricarboxylic acid cycle.

Showing all 14 steps.

Regulation

What speeds each enzyme up and what slows it down

Dihydropyrimidine dehydrogenase (DPD)

Accelerated by

Uracil/thymine availability; adequate NADPH

Inhibited by

5-ethynyluracil and pharmacologic DPD inhibitors; genetic deficiency markedly lowers activity

Hormonal

No major direct hormonal regulation; expression/activity vary substantially among individuals and tissues.

Dihydropyrimidinase

Accelerated by

Dihydropyrimidine availability

Inhibited by

Product accumulation; inherited loss of function

Hormonal

No established direct hormonal control.

Beta-ureidopropionase

Accelerated by

N-carbamyl-beta-amino acid availability

Inhibited by

Product effects; inherited loss of function

Hormonal

No established direct hormonal control.

Propionyl-CoA carboxylase (downstream thymine-carbon handling)

Accelerated by

Propionyl-CoA and bicarbonate availability

Inhibited by

Biotin deficiency and loss-of-function variants impair activity

Hormonal

Metabolic/nutritional state influences substrate flow; no defining acute hormonal allostery.

Overview

Pyrimidine nucleotides are degraded to highly water-soluble, small metabolites rather than to a poorly soluble terminal product such as urate. Uracil yields beta-alanine, whereas thymine yields beta-aminoisobutyrate; the carbon skeletons can enter central metabolism. Cytosine is first deaminated at the nucleoside level in humans, so its degradation converges with the uracil pathway.

Cellular location

Initial nucleotidase, nucleoside phosphorylase, and deaminase reactions occur mainly in the cytosol. The reductive ring-opening pathway is primarily hepatic but is also present in other tissues; the first enzyme, dihydropyrimidine dehydrogenase (DPD), is associated with the cytosolic face of the endoplasmic reticulum. Subsequent catabolic products are handled in cytosolic and mitochondrial reactions, with liver and kidney important for nitrogen disposal and further oxidation.

Net energetics

Conversion of uracil or thymine to the corresponding dihydropyrimidine consumes one NADPH at the DPD step; ring opening and carbamyl-group hydrolysis do not directly consume ATP. Subsequent oxidation of malonate or methylmalonate semialdehyde produces NADH and activated acyl-CoA products. Complete entry of thymine-derived propionyl-CoA into the tricarboxylic acid cycle requires one ATP → ADP equivalent at propionyl-CoA carboxylase and adenosylcobalamin for methylmalonyl-CoA mutase.

Clinical significance

Pyrimidine degradation prevents accumulation of bases/nucleosides and recovers their carbon skeletons as acetyl-CoA or succinyl-CoA, unlike purine catabolism, which terminates at urate. DPD is the major enzyme that catabolizes 5-fluorouracil; partial or complete DPD deficiency can cause life-threatening fluoropyrimidine toxicity, including severe mucositis, diarrhea, cytopenias, and neurotoxicity, at standard doses. Dihydropyrimidinase and beta-ureidopropionase deficiencies are rare inborn errors associated with variable neurologic manifestations and abnormal urinary pyrimidine metabolites. Elevated beta-aminoisobutyrate excretion may occur with increased thymine turnover or metabolic variation.

Recent literature

Live Europe PMC search

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Spatial ecology of the <i>Capnocytophaga</i> genus in the human oral cavity.

    Giacomini JJ, Torres-Morales J, Dewhirst FE, Borisy GG, Mark Welch JL. · 2026-04-30

    open access unreviewed
  2. 2
    β-ureidopropionase deficiency mimicking Leigh syndrome associated with methylmalonic aciduria.

    Ferrera G, Boenzi S, Lamantea E, Ghezzi D, Ardissone A. · 2026-05-04

    unreviewed
  3. 3
  4. 4
    From Serum to Genome: γ-Glutamyltransferase Gene Family Variants Shape Ischemic Stroke Risk via Sex-Specific Gene-Environment Interactions.

    Solodilova M, Drozdova E, Azarova I, Bykanova M, Bushueva O, Puchkova A, Puchkov V, Freidin M, Churnosov M, P… · 2026-04-24

    open access unreviewed
  5. 5
    Response of gut microbiome and metabolomic profiles to POLYCAN, a β-glucan derived from Aureobasidium pullulans SM-2001 in beagles.

    Sampath V, Lee K, Kim M, Kim YS, Min DH, Han K, Cho S, Kang DK, Kim IH. · 2026-04-10

    open access unreviewed
  6. 6
    Osmotolerance is a driver of microbial carbon processes in the Elbe estuary.

    Tobias-Hünefeldt SP, Woodhouse JN, Ruscheweyh H-J, Sunagawa S, Russnak V, Streit WR, Grossart H-P. · 2026-03-30

    cited 1× open access unreviewed
  7. 7
    Single-cell sequencing reveals unexpected genetic diversity among <i>Bodo</i> spp. flagellates and their bacterial endosymbionts.

    Warring SD, McGowan J, Kilias ES, Lipscombe J, Alacid E, Barker T, Catchpole L, Gharbi K, McTaggart S, Richar… · 2026-03-01

    open access unreviewed
  8. 8
    Sub-daily virus sampling at the Bermuda Atlantic Time Series reveals diel and depth-structured population dynamics without community-level shifts.

    Carrillo A, Hageman E, Chittick L, Mackey AI, Ndlovu KS, Tian F, Gilbert NE, Muratore D, Vik D, LeCleir GR, S… · 2026-03-06

    open access unreviewed
  9. 9
    Integrated Bacterial Community and Differential Metabolites Reveal the Impact of Growth Stage on the Quality of Oat Silage.

    Ren J, Han L, Ma X, Liu X, Hao Y, Yuan J, Ding Z, Li X, Wang J, Sun J. · 2026-02-24

    open access unreviewed
  10. 10
    Urate metabolism in the gut.

    Percudani R. · 2025-11-22

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.